Blood Pressure Management in Stroke Following Endovascular Treatment
Conditions:   Stroke, Acute;   Vessels; Occlusion;   Blood Pressure;   Endovascular Thrombectomy;   Mechanical Thrombectomy Interventions:   Drug: Labetalol;   Drug: Hydralazine;   Drug: Enalapril Sponsor:   Hamilton Health Sciences Corporation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 23, 2020 Category: Research Source Type: clinical trials

Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period
Conditions:   Hypertension in Pregnancy;   Preeclampsia Severe;   Gestational Hypertension;   Postpartum Preeclampsia;   Postpartum Interventions:   Drug: NIFEdipine ER;   Drug: Enalapril Sponsor:   Brigham and Women's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2020 Category: Research Source Type: clinical trials

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy
Conditions:   C3 Glomerulopathy;   Membranoproliferative Glomerulonephritis;   Complement Abnormality;   Dense Deposit Disease;   C3 Glomerulonephritis Interventions:   Drug: Aliskiren;   Drug: Enalapril Sponsor:   Region Skane Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2019 Category: Research Source Type: clinical trials

A Multicenter, Randomized Study to Evaluate Sacubitril/Valsartan vs Enalapril in LVAD Recipients
Condition:   Heart Failure Interventions:   Drug: Sacubitril-Valsartan;   Drug: Enalapril Sponsor:   University of Zagreb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2019 Category: Research Source Type: clinical trials

Sacubitril/Valsartan in Left Ventricular Assist Device Recipients
Condition:   Heart Failure Interventions:   Drug: Sacubitril-Valsartan;   Drug: Enalapril Sponsor:   University of Zagreb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 25, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC
Conditions:   Chagas Disease;   Heart Failure Interventions:   Drug: Sacubitril/valsartan;   Drug: Enalapril Sponsor:   Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2019 Category: Research Source Type: clinical trials